Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Pregnancy Test Tells When Conception Occurred

By LabMedica International staff writers
Posted on 29 Sep 2008
A one-step rapid pregnancy test also indicates an approximate date of conception.

The test is very simple and accurate. More...
Urine is applied to an absorbent sampler activating the test, which automatically calibrates itself. A "Wait” symbol on the liquid crystal display (LCD) display screen indicates the test is working. Within three minutes, an easy to read result is displayed. If the test is positive, "Pregnant” will be indicated in words on the display along with the Conception Indicator result. This is displayed as an estimate of how many weeks have occurred since conception: 1-2 weeks, 2-3 weeks or 3+ weeks.

Once a fertilized egg implants in the uterus wall, a woman's body produces the pregnancy hormone, human chorionic gonadotropin (hCG). This rapidly increases during the early weeks of pregnancy and is present in urine. It is this hormone that pregnancy tests detect when confirming a positive result. Clearblue (Waltham, MA, USA) launched the Clearblue digital pregnancy test with Conception Indicator--the only pregnancy test that is so advanced it is capable of telling a woman both if she is pregnant, and provide an indication when she might have conceived.

In laboratory tests, Clearblue digital pregnancy test is more than 99% accurate in detecting pregnancy, when used from the day the period is due. The Conception Indicator result is 92% accurate at indicating when a woman conceived, and when using the first urine of the day. As with the original Clearblue digital pregnancy test, the Conception Indicator is a one-step rapid test designed to be used once before disposal.

Clearblue launched the new test following extensive clinical studies to pinpoint the different levels of hCG required to estimate when conception occurred. Dr. Jayne Ellis, director of new product development at Clearblue commented, "The Conception Indicator is something we have been researching for a number of years, and the final product is unique. We are excited to be able to offer women more valuable information about their pregnancy as soon as the "pregnant” result is confirmed.”

Related Links:
Clearblue



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.